The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects
Open accessAbstract
Exposure to drugs during pregnancy has the potential to harm offspring. Teratogenic effects are the most feared adverse outcomes in newborns; however, a wide spectrum of less known, usually reversible and often acute, neonatal adverse events can also occur due to drug intake by mothers during pregnancy, particularly in close proximity to delivery. This narrative review is aimed at the description of drugs and drug classes for which licit maternal use in the predelivery period has been associated with neonatal non-teratogenic disorders. For each drug class, epidemiology, clinical features, biological mechanism and management of these adverse reactions have been discussed in detail. Although these adverse reactions have been described mainly for substances used illicitly for recreational purposes, several prescription drugs have also been involved; these include mainly psychotropic medications such as opioids, antidepressants, antiepileptics and antipsychotics. These effects can be partly explained by withdrawal syndromes (defined also as 'neonatal abstinence syndrome') caused by the delivery-related discontinuation of the drug disposition from the mother to the fetus, with symptoms that may include feeding disorders, tremors, irritability, hypotonia/hypertonia, vomiting and persistent crying, occurring a few hours to 1 month after delivery. Otherwise, neonatal neurological and behavioral effects can also be caused by a residual pharmacological effect due to an accumulation of the drug in the blood and tissues of the newborn, with various symptoms related to the toxic effects of the specific drug class, usually developing a few hours after birth. With few exceptions, validated protocols for the assessment and management of withdrawal or residual pharmacological effects of these drugs in neonates are often lacking or incomplete. Spontaneous reporting of these adverse reactions seems limited, although it might represent a useful tool for improving our knowledge about drug-induced neonatal syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both neonatal BZD withdrawal and FIS typically present within the first hours of life and continue for up to 14 days.184”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [184]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Floppy infant syndrome (FIS)—which presents with hypotonia, lethargy, sucking difficulties, low Apgar score, hypothermia, apnea, cyanosis, hyperbilirubinemia, and CNS depression—has also been observed in newborns who have been exposed to BZDs in utero during the third trimester and may be a result of BZD toxicity.184,185”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–315 of 315
Treatment of Neonatal Withdrawal with Clonidine After Long-Term, High-Dose Maternal Use of Tramadol
O'Mara, K. L., Gál, P., & Davanzo, C. C. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m758 · Cited by 34
Neonatal alprazolam withdrawal—possible effects of breast feeding
Anderson, P. O., & McGuire, G. G. (1989) · DICP · doi:10.1177/1060028089023007-822 · Cited by 33
Neonatal seizures from in utero venlafaxine exposure
Pakalapati, R. K., Bolisetty, S., Austin, M., & Oei, J. L. (2006) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2006.00962.x · Cited by 33
Neonatal seizures associated with maternal hydroxyzine hydrochloride in late pregnancy
Serreau, R., Komiha, M., Blanc, F., Guillot, F., & Jacqz-Aigrain, É. (2005) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.03.005 · Cited by 33
Clonidine: placental transfer and neonatal adaption
Boutroy, M., Gisonna, C. R., & Legagneur, M. (1988) · Early Human Development · doi:10.1016/s0378-3782(88)80014-8 · Cited by 32
Karakuła‐Juchnowicz, H., Szajer, K., Śpila, B., Grzywa, A., & Chuchra, M. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832689 · Cited by 32
Maternal clozapine treatment and decreased fetal heart rate variability
Yogev, Y., Ben‐Haroush, A., & Kaplan, B. (2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00276-x · Cited by 32
The Safety of Duloxetine During Pregnancy and Lactation
Andrade, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14f09631 · Cited by 31
Developing diagnostic criteria for the fetal anticonvulsant syndromes
Dean, J., Moore, S., & Turnpenny, P. D. (2000) · Seizure · doi:10.1053/seiz.2000.0392 · Cited by 31
Is the 50-gram glucose screening test ever diagnostic?
Bobrowski, R. A., Bottoms, S. F., Micallef, J., & Dombrowski, M. P. (1996) · The Journal of Maternal-Fetal Medicine · doi:10.1002/(sici)1520-6661(199611/12)5:6<348::aid-mfm11>3.0.co;2-d · Cited by 31
Neonatal barbiturate withdrawal
Blumenthal, I., & Lindsay, S. M. (1977) · Postgraduate Medical Journal · doi:10.1136/pgmj.53.617.157 · Cited by 31
Neonatal abstinence syndrome due to codeine
Khan, K. S., & Chang, J. (1997) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.76.1.f59 · Cited by 30
[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
Bloem, B. R., Roofthooft, D. W. E., Lammers, G. J., de Beaufort, A., & Of, B. (2003) · PubMed · Cited by 30
The Use Of Flumazenil In A Neonate
Richard, P., AUTRET, E., Bardol, J., Soyez, C., Barbier, P., Jonville‐Béra, A. ‐., & Ramponi, N. (1991) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659109038604 · Cited by 29
Fluphenazine decanoate during pregnancy
Cleary, M. F. (1977) · American Journal of Psychiatry · doi:10.1176/ajp.134.7.815 · Cited by 29
Poor Neonatal Adaptation After in Utero Exposure to Duloxetine
Eyal, R., & Yaeger, D. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071194 · Cited by 28
"FLOPPY INFANT SYNDROME" AND MATERNAL DIAZEPAM
Haram, K. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91463-5 · Cited by 28
Clomipramine concentration and withdrawal symptoms in 10 neonates
ter Horst, P. G. J., van der Linde, S., Smit, J. P., den Boon, J., van Lingen, R. A., Jansman, F. G. A., den Berg, L. T. W. D. J., & Wilffert, B. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04072.x · Cited by 28
Disappearance from the newborn of circulating prenatally administered phenobarbital
Jalling, B., Bor�us, L. O., K�llberg, N., & Agurell, S. (1973) · European Journal of Clinical Pharmacology · doi:10.1007/bf00644738 · Cited by 27
Paroxetine withdrawal in a neonate with historical and laboratory confirmation
Jaiswal, S., Coombs, R. C., & Isbister, G. K. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1293-9 · Cited by 27
Neonatal Abstinence Syndrome and Cerebral Infarction Following Maternal Codeine Use During Pregnancy
Reynolds, E. W., Riel-Romero, R. M. S., & Bada, H. S. (2007) · Clinical Pediatrics · doi:10.1177/0009922807300795 · Cited by 27
Managing Psychosis in Pregnancy
McCauley-Elsom, K. M., & Kulkarni, J. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601172798 · Cited by 26
Narcotic Withdrawal Reaction in a Newborn Infant Due to Codeine
Leeuwen, G. V., Guthrie, R., & Stange, F. (1965) · PEDIATRICS · doi:10.1542/peds.36.4.635 · Cited by 25
Mendhekar, D. N., Sharma, J. B., Srivastava, P. K., & War, L. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0718e · Cited by 25
García‐Algar, Ó., López-Vílchez, M. Á., Martín, I. C., Mǔr, A., Pellegrini, M., Pacifici, R., Rossi, S., & Pichini, S. (2007) · Clinical Toxicology · doi:10.1080/15563650601072191 · Cited by 25
Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother
Willaschek, C., Wolter, E., & Buchhorn, R. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0598-z · Cited by 25
Diazepam in Preeclamptic Toxaemia with Special Reference to its Effect on the Newborn Infant
Shannon, R. W., Fraser, G. P., Aitken, R. G., & Harper, J. R. (1972) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1972.tb04440.x · Cited by 25
Selective serotonin reuptake inhibitors in pregnancy and infant outcomes
Jefferies, A. L. (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.9.562 · Cited by 24
Neonatal withdrawal symptoms associated with maternal use of pentazocine
Goetz, R. L., & Bain, R. V. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80775-4 · Cited by 24
Neonatal withdrawal symptoms associated with maternal use of propoxyphene hydrochloride (Darvon)
Tyson, H. K. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80519-6 · Cited by 24
Lorazepam premedication for labour
McAULEY, D. M., O'Neill, M., MOORE, J., & Dundee, J. W. (1982) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1982.tb04683.x · Cited by 23
Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy: Table 1
Bot, P. T. G., Semmekrot, B. A., & van der Stappen, J. (2006) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2004.066431 · Cited by 23
Maternal Buprenorphine Dose at Delivery and Its Relationship to Neonatal Outcomes
O’Connor, A. B., O’Brien, L. M., & Alto, W. A. (2015) · European Addiction Research · doi:10.1159/000441220 · Cited by 23
Onthoudingsverschijnselen bij een neonatus na blootstelling aan venlafaxine tijdens de zwangerschap
Moor, R., Mourad, L. M., ter Haar, J., & Egberts, T. C. G. (2003) · Utrecht University Repository (Utrecht University) · Cited by 23
Neonatal Abstinence Syndrome: Strategies for Care of the Drug-Exposed Infant
Greene, C., & Goodman, M. J. (2003) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.22.4.15 · Cited by 22
Tramadol withdrawal in a neonate
Meyer, F. P., Rimasch, H., Blaha, B., & Banditt, P. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050356 · Cited by 22
Prenatally buprenorphine-exposed children: health to 3 years of age
Kivistö, K., Tupola, S. J., & Kivitie‐Kallio, S. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2562-0 · Cited by 21
Opioid Neonatal Abstinence Syndrome: Controversies and Implications for Practice
Wolff, K., & Perez-Montejano, R. (2014) · Current Drug Abuse Reviews · doi:10.2174/1874473707666141015215141 · Cited by 21
McGrath, C., Buist, A., & Norman, T. R. (1999) · Drug Safety · doi:10.2165/00002018-199920020-00006 · Cited by 20
Welle-Strand, G. K., Skurtveit, S. O., Tanum, L., Waal, H., Bakstad, B., Bjarkø, L., & Ravndal, E. (2015) · European Addiction Research · doi:10.1159/000381670 · Cited by 20
Serotonin syndrome in a breast-fed neonate
Morris, R., & Matthes, J. (2015) · BMJ Case Reports · doi:10.1136/bcr-2015-209418 · Cited by 20
Possible effect of chlordiazepoxide on the fetus.
Bitnun, S. (1969) · PubMed Central · Cited by 20
Reversal of fetal benzodiazepine intoxication using flumazenil
Stahl, M. M. S., Saldeen, P., & Vinge, E. (1993) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1993.tb15221.x · Cited by 20
Teratogenic determinants of first-trimester exposure to antiepileptic medications.
Brosh, K., Matok, I., Sheiner, E., Koren, G., Wiznitzer, A., Gorodischer, R., & Levy, A. (2011) · PubMed · Cited by 18
Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome
Jordan, A. E., Jackson, G. L., Deardorff, D., Shivakumar, G., McIntire, D. D., & Dashe, J. S. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050802255488 · Cited by 18
Paroxetine Use During Pregnancy: Is it Safe?
Thormahlen, G. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h116 · Cited by 18
Neonatal withdrawal syndrome: reaching epidemic proportions across the globe
Allegaert, K., & van den Anker, J. N. (2015) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2015-309566 · Cited by 17
Letter: Transplacental passage of chlordiazepoxide.
Stirrat, G. M., Edington, P. T., & Berry, D. J. (1974) · BMJ · doi:10.1136/bmj.2.5921.729-b · Cited by 17
Transient Neonatal Jitteriness due to Maternal Use of Sertraline (Zoloft®)
Santos, R. P., & Pergolizzi, J. J. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211115 · Cited by 17
In Utero Oxcarbazepine and a Withdrawal Syndrome, Anomalies, and Hyponatremia
Rolnitsky, A., Merlob, P., & Klinger, G. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.02.012 · Cited by 17
Koren, G., Finkelstein, Y., Matsui, D. M., & Berkovitch, M. (2009) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34157-3 · Cited by 16
Assessment of GABA A benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines
Potokar, J. P., Coupland, N., Wilson, S. J., Rich, A., & Nutt, D. (1999) · Psychopharmacology · doi:10.1007/s002130051104 · Cited by 16
Leibovitch, L., Rymer‐Haskel, N., Schushan‐Eisen, I., Kuint, J., Strauss, T., & Maayan‐Metzger, A. (2013) · Neonatology · doi:10.1159/000350506 · Cited by 16
Neonatal abstinence syndrome (NAS) after intrauterine exposure to tramadol
Hartenstein, S., Proquitté, H., Bauer, S., Bamberg, C., & Roehr, C. C. (2010) · Journal of Perinatal Medicine · doi:10.1515/jpm.2010.102 · Cited by 16
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects
Friedman, J. M. (2012) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23043 · Cited by 16
Nako, Y., Tachibana, A., Fujiu, T., Tomomasa, T., & Morikawa, A. (2001) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.84.3.f198 · Cited by 15
Pentazocine and neonatal withdrawal symptoms
Scanlon, J. W. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80536-6 · Cited by 15
Letter: Withdrawal symptoms in newborn infants of epileptic mothers.
Erith, M. J. (1975) · BMJ · doi:10.1136/bmj.3.5974.40 · Cited by 14
Use of baclofen for withdrawal in a preterm infant
Duncan, S. D., & Devlin, L. A. (2013) · Journal of Perinatology · doi:10.1038/jp.2012.107 · Cited by 14
Valproic acid transfer across human placental cotyledon during dual perfusion in vitro.
Semczuk‐Sikora, A., Czuczwar, S. J., Semczuk, A., Kwaśniewska, A., & Semczuk, M. (2010) · PubMed · Cited by 14
Probable Neonatal Propoxyphene Withdrawal: A Case Report
Klein, R. B., Blatman, S., & Little, G. A. (1975) · PEDIATRICS · doi:10.1542/peds.55.6.882 · Cited by 14
Kriel, R. L., & Cloyd, J. C. (1982) · Annals of Neurology · doi:10.1002/ana.410110518 · Cited by 13
Buprénorphine (Subutex®) et syndrome de sevrage néonatal
Hervé, F., & Quenum, S. (1998) · Archives de Pédiatrie · doi:10.1016/s0929-693x(97)86842-x · Cited by 13
Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use
Weintraub, Z., Bental, Y. A., OLIVAN, A., & Rotschild, A. (1998) · Addiction Biology · doi:10.1080/13556219872227 · Cited by 13
Neonatal withdrawal syndrome due to maternal codeine use
Nair, V., Soraisham, A. S., & Akierman, A. (2012) · Paediatrics & Child Health · doi:10.1093/pch/17.5.e40 · Cited by 12
Decancq, H. G., Bosco, J. R., & Townsend, E. H. (1965) · The Journal of Pediatrics · doi:10.1016/s0022-3476(65)80375-4 · Cited by 12
The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero
Burja, S., Rakovec-Felser, Z., Treiber, M., Hajdinjak, D., & Gajšek-Marchetti, M. (2006) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0539-8 · Cited by 12
Prolonged neonatal complications afterin uteroexposure to fluoxetine
Alehan, F., Saygı, S., Tarcan, A., & Gürakan, B. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050802266899 · Cited by 12
Gordon, A. L., Lopatko, O. V., Haslam, R. R., Stacey, H., Pearson, V., Woods, A., Fisk, A., & White, J. M. (2012) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000190 · Cited by 12
Neonatal episodic hypoglycemia: A finding of valproic acid withdrawal
Çoban, D., Kurtoğlu, S., Akın, M. A., Akçakuş, M., & Güneş, T. (2010) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v2i2.92 · Cited by 11
Nath, S. P., Miller, D. A., & Muraskas, J. K. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000106 · Cited by 11
Neonatal Drug Withdrawal From Propoxyphene
Quillian, W. W. (1976) · JAMA · doi:10.1001/jama.1976.03260450040031 · Cited by 11
"Floppy infant" en gemelos por uso de benzodiacepinas durante la gestación
de Dios, J. G., Benavent, M. M., & Carratalá-Marco, F. (1999) · Revista de Neurología · doi:10.33588/rn.2902.98464 · Cited by 11
Backes, C. R., & Cordero, L. (1980) · PubMed · Cited by 10
Prenatal Care for Pregnant Chronic Mentally Ill Patients
Miller, W. H., Bloom, J. D., & Resnick, M. P. (1992) · Psychiatric Services · doi:10.1176/ps.43.9.942 · Cited by 10
Flumazenil reverses diazepam-induced neonatal apnoea and hypotonia
Cone, A., Nadel, S., & Sweeney, B. (1993) · European Journal of Pediatrics · doi:10.1007/bf01955914 · Cited by 10
A New Indication for Therapeutic Drug Monitoring in the Neonate
Koren, G. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000187973.02624.67 · Cited by 10
Safety of escitalopram in pregnancy: a case series
Orsolini, L., Bellantuono, & Bozzi (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45951 · Cited by 10
Rapid-eye-movement sleep in jittery infants
Shimohira, M., Iwakawa, Y., & Kohyama, J. (2002) · Early Human Development · doi:10.1016/s0378-3782(01)00232-8 · Cited by 9
Sabatowski, R., Radbruch, L., Grond, S., & Göhring, U.-J. (2000) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2000.440323.x · Cited by 9
Bidlack, J. M., & Morris, H. H. (2008) · Seizure · doi:10.1016/j.seizure.2008.06.014 · Cited by 9
Breastfeeding and psychotropic medications
Worsley, R., Gilbert, H., Gavrilidis, E., Naughton, B., & Kulkarni, J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60671-6 · Cited by 9
Maternal Methadone Treatment and Neonatal Abstinence Syndrome
Singh, K., Faisal, M., Li, S., & Liu, W. (2015) · American Journal of Perinatology · doi:10.1055/s-0035-1549218 · Cited by 9
Neonatal Toxicity Following Maternal Citalopram Treatment
Eleftheriou, G., Butera, R., Cottini, F. C., Bonati, M. R., & Farina, M. (2013) · Fetal and Pediatric Pathology · doi:10.3109/15513815.2013.768743 · Cited by 9
Side-effects of maternal diazepam on the newborn infant.
Woods, D. L., & Malan, A. F. (1978) · PubMed · Cited by 9
Diazepam (valium) during labor.
Nisbet, R. B., BOULAS, S. H., & Kantor, H. I. (1967) · PubMed · Cited by 9
[Neonatal withdrawal symptoms following the use of clomipramine during pregnancy].
Jb, B., Jong, D. C., & Touw, D. J. (1992) · PubMed · Cited by 9
Fluoxetine withdrawal syndrome in the newborn.
Anbu, A. T., & Theodore, A. (2006) · PubMed · Cited by 9
Paroxetine and neonatal withdrawal syndrome
Pogliani, L., Schneider, L. A., Dilillo, D., Penagini, F., & Zuccotti, G. (2010) · BMJ Case Reports · doi:10.1136/bcr.12.2009.2528 · Cited by 8
FLOPPY-INFANT SYNDROME: IS OXAZEPAM THE ANSWER?
Drury, K. A. D., Spalding, E., Donaldson, D. I., & Rutherford, D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90565-7 · Cited by 8
Neonatal seizures after use of pyridoxine in pregnancy
Smith, M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00306-2 · Cited by 8
Zuppa, A. A., Carducci, C., Scorrano, A., Antichi, E., Catenazzi, P., Piras, A., Pozzoli, G., Cardiello, V., D’Antuono, A., & Romagnoli, C. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.06.035 · Cited by 8
Duloxetine Withdrawal Syndrome in a Newborn
Abdy, N. A., & Gerhart, K. D. (2012) · Clinical Pediatrics · doi:10.1177/0009922812450509 · Cited by 8
La sicurezza dell’escitalopram in gravidanza e nell’allattamento
Bellantuono, C., Orsolini, L., & Bozzi, F. (2013) · Rivista di psichiatria · doi:10.1708/1379.15335 · Cited by 7
Valproic acid-induced rapid changes of met-enkephalin levels in rat brain
Asai, M., Talavera, E., Massarini, A., Zubieta, M., & Vindrola, O. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90071-x · Cited by 7
Castle, D. J., McGrath, J., & Kulkarni, J. (2000) · Cited by 7
[Neonatal abstinence syndrome after maternal use of tramadol].
de Wit, D., & Koomen-Botman, I. (2013) · PubMed · Cited by 6
Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine
Murray, K. L., Miller, K., & Pearson, D. L. (2007) · Journal of Perinatology · doi:10.1038/sj.jp.7211772 · Cited by 6
[Oxazepam withdrawal in the neonatal period].
Rane, A., Sundwall, A., & Tomson, G. B. (1979) · PubMed · Cited by 6
Neonatal convulsions secondary to paroxetine withdrawal.
Ahmed, M., Parameshwaran, A., & Swamy, P. D. (2007) · PubMed · Cited by 6
Neugeborenen-Krämpfe durch Lamotrigin-Entzug?
Vieker, S., Thiel, M. T., & Längler, A. (2009) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/s-0029-1214404 · Cited by 5
Is there anything new on the use of psychotropic drugs during pregnancy?
Shader, R. I. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00021 · Cited by 5
Can we use anxiolytics during pregnancy without anxiety?
Addis, A., Dolovich, L. R., Einarson, T. R., & Koren, G. (2000) · PubMed · Cited by 5
Premedication for elective Caesarean section
Crawford, J. S. (1979) · Anaesthesia · doi:10.1111/j.1365-2044.1979.tb08542.x · Cited by 5
Myoclonic seizures in a preterm baby: is this a presentation of venlafaxine withdrawal?
Ansary, A., Ibhanesebhor, S., & Manjunatha, C. (2014) · Singapore Medical Journal · doi:10.11622/smedj.2014061 · Cited by 5
Neonatal pentazocine withdrawal syndrome--a case report of conservative treatment.
Wh, W., Rj, T., & Hy, S. (1988) · PubMed · Cited by 5
Special Needs of Women With Bipolar Disorder
Swann, A. C. (2004) · CNS Spectrums · doi:10.1017/s1092852900029047 · Cited by 5
Effects of exposure to benzodiazepine during fetal life
Bergman, U., Rosa, F., Baum, C., Be, W., & Faich, G. (1993) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(93)90753-j · Cited by 4
Convulsions néonatales, syndrome de sevrage à la buprénorphine et traitement morphinique substitutif
Dahan, S., Éléfant, É., Girard, I., Azcona, B., Champion, V., & Mitanchez, D. (2011) · Archives de Pédiatrie · doi:10.1016/j.arcped.2010.12.003 · Cited by 4
Bavoux, F., Lanfranchi, C., Olivé, G., Asensi, D., Dulac, O., Francoual, C., HUAULT, G., Olivier, C., Seilaniantz, M., Castot, A., et al. (1981) · PubMed · Cited by 4
Neonatal withdrawal from propoxyphene hydrochloride.
Ente, G., & Mehra, M. C. (1978) · PubMed · Cited by 4
Decancq, H. G., Bosco, J. R., & Townsend, E. H. (1966) · Survey of Anesthesiology · doi:10.1097/00132586-196612000-00012 · Cited by 3
[Intranatal Administration of midazolam (author's transl)].
Gitsch, E., Philipp, K.-P., & Schönbauer, M. (1982) · PubMed · Cited by 3
Neonatal behaviour and maternal barbiturates.
(1972) · BMJ · doi:10.1136/bmj.4.5832.63-a · Cited by 3
Syndrome de sevrage chez un nouveau-né de mère toxicomane recevant de la méthadone
Baglin, S., Avenel, S., Renaud, C., Bavoux, F., Francoual, C., & Badoual, J. (1995) · Archives de Pédiatrie · doi:10.1016/0929-693x(96)81235-8 · Cited by 2
Research works printed but not linked: 7
- Hagopian GS, Wolfe HM, Sokol RJ, Ager JW, Wardell JN, Cepeda EE. Neonatal outcome following methadone exposure in utero. J Matern Fetal Med. 1996;5(6):348–54.
- Bellantuono C, Orsolini L, Bozzi F. The safety profile of escitalopram in pregnancy and breastfeeding [in Italian]. Riv Psichiatr. 2013;48(6):407–14.
- Gonzalez de Dios J, Moya-Benavent M, Carratala-Marco F. “Floppy infant” syndrome in twins secondary to the use of benzodiazepines during pregnancy [in Spanish]. Rev Neurol. 1999;29(2):121–3.
- Taylor D, Paton C, Kapur S. Prescribing guidelines in psychiatry. 11th ed. CornWall: Wiley; 2012.
- Bazire S. Psychotropic drug directory. Salisbury: Fivepin Limited; 2005:239.
- Dev VJKP. Adverse event profile and safety of clozapine. Rev Contemp Pharmacother. 1995;6:197–208.
- Vavrusova LKM. Clozapine administration during pregnancy [in Czechoslovakian]. Ceska Slov Psychiatr. 1998;94:282–5.
Cited by
An advanced human in vitro co-culture model for translocation studies across the placental barrier
Aengenheister, L., Keevend, K., Muoth, C., Schönenberger, R., Diener, L., Wick, P., & Buerki‐Thurnherr, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-23410-6 · Cited by 133
Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies
Raffaeli, G., Cavallaro, G., Allegaert, K., Wildschut, E. D., Fumagalli, M., Agosti, M. A., Tibboel, D., & Mosca, F. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1954 · Cited by 64
“At delivery time, the decrease of serotonin transmission, as a consequence of both SNRI and SSRI discontinuation and receptor desensitization, has an impact on the other pathways involved.(29) For those neonates whose mothers use TCAs, withdrawal symptoms result from a “cholinergic overdrive phenomenon,” promoted by t…”
BackgroundInfluentialBrunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
“184,185 Both neonatal BZD withdrawal and FIS typically present within the first hours of life and continue for up to 14 days.”
Umer, A., Loudin, S., Maxwell, S. R., Lilly, C. L., Stabler, M. E., Cottrell, L., Hamilton, C., Breyel, J., Mullins, C., & John, C. C. (2018) · Pediatric Research · doi:10.1038/s41390-018-0172-z · Cited by 26
Eleftheriou, G., Zandonella Callegher, R., Butera, R., De Santis, M., Cavaliere, A. F., Vecchio, S., Pistelli, A., Mangili, G., Bondi, E., Somaini, L., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20166565 · Cited by 17
“The onset and duration of symptoms correlate with the pharmacokinetics and placental disposition of benzodiazepines [227].”
Background
Metadata
- Authors
- Convertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Tuccori, Marco
- Venue
- Drug Safety
- Published
- 2016-10
- Volume
- 39
- Issue
- 10
- Pages
- 903-924
- ISSN
- 0114-5916 (ISSN-L)
- 1179-1942
- OpenAlex
- W2409304735
- Cited by
- 32
- References
- 315
- Citations by year
- 2025: 3 · 2024: 7 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 3
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- green
- link.springer.com
- Licence
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
- Electronic Theses and Dissertations Repository (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- neonatal abstinence syndrome, withdrawal syndrome, psychotropic drugs, opioids, antidepressants, antiepileptic drugs, antipsychotic drugs, neonatal feeding disorders, adverse drug reaction reporting
- MeSH terms
- Adaptation, Physiological, Female, Humans, Infant, Newborn, Neonatal Abstinence Syndrome, Pregnancy, Psychotropic Drugs, Prescription Drugs, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.